Research ArticleCLINICAL INVESTIGATIONS
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
Einat Even-Sapir, Ur Metser, Eyal Mishani, Gennady Lievshitz, Hedva Lerman and Ilan Leibovitch
Journal of Nuclear Medicine February 2006, 47 (2) 287-297;
Einat Even-Sapir
Ur Metser
Eyal Mishani
Gennady Lievshitz
Hedva Lerman
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
Einat Even-Sapir, Ur Metser, Eyal Mishani, Gennady Lievshitz, Hedva Lerman, Ilan Leibovitch
Journal of Nuclear Medicine Feb 2006, 47 (2) 287-297;
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
Einat Even-Sapir, Ur Metser, Eyal Mishani, Gennady Lievshitz, Hedva Lerman, Ilan Leibovitch
Journal of Nuclear Medicine Feb 2006, 47 (2) 287-297;
Related Articles
Cited By...
- Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study
- Whole-Skeleton SUVmean Measured on 18F-NaF PET/CT Studies as a Prognostic Indicator in Patients with Breast Cancer Metastatic to Bone
- Skeletal sarcoidosis; an uncommon mimic of metastatic disease
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Observer Agreement and Accuracy of 18F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer
- 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
- No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy
- Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in 18F-Fluoride PET/CT
- SNMMI Procedure Standard for Bone Scintigraphy 4.0
- Validation of the Semiautomatic Quantification of 18F-Fluoride PET/CT Whole-Body Skeletal Tumor Burden
- Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
- A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
- Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer
- Imaging Cardiovascular Calcification
- The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer
- Anatomic and Molecular Imaging in Prostate Cancer
- The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer
- Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
- Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
- Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
- Evaluation of Prostate Cancer with PET/MRI
- Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
- Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
- Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
- Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer
- Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT
- Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies
- Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
- Evaluation of 18F-Fluoride PET/MR and PET/CT in Patients with Foot Pain of Unclear Cause
- Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of Prostate Cancer
- Picture the future: emerging imaging modalities
- Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
- PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications
- PET/CT with Sodium 18F-Fluoride for Management of Patients with Prostate Cancer
- Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry
- Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study
- Unmet Needs in the Prediction and Detection of Metastases in Prostate Cancer
- Clinical utility of fluoride-18 positron emission tomography/CT in temporomandibular disorder with osteoarthritis: comparisons with 99mTc-MDP bone scan
- Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial
- Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- Measuring Oncogenic Signaling Pathways in Cancer with PET: An Emerging Paradigm from Studies in Castration-Resistant Prostate Cancer
- Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients
- The Kinetics and Reproducibility of 18F-Sodium Fluoride for Oncology Using Current PET Camera Technology
- Coronary Arterial 18F-Sodium Fluoride Uptake: A Novel Marker of Plaque Biology
- Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen
- Androgen-Independent Molecular Imaging Vectors to Detect Castration-Resistant and Metastatic Prostate Cancer
- SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0
- Assessment of Patient Exposure to X-Radiation from SPECT/CT Scanners
- Usefulness of Combined FDG-PET with CT or Tumour Markers in Lung Cancer Diagnosis
- The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors
- New Agents and Techniques for Imaging Prostate Cancer
- Novel Strategy for a Cocktail 18F-Fluoride and 18F-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study
- Magnetic Resonance Imaging Versus Bone Scan in High-Risk Prostatic Carcinoma: Some Methodological Considerations
- Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer
- Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies
- An Introduction to Na18F Bone Scintigraphy: Basic Principles, Advanced Imaging Concepts, and Case Examples
- SPECT/Multislice Low-Dose CT: A Clinically Relevant Constituent in the Imaging Algorithm of Nononcologic Patients Referred for Bone Scintigraphy